Going global, Takeda opens up 165,000-square-foot R&D facility in San Diego
Months after consummating its hefty $62 billion deal to buy Ireland’s Shire, Japanese drugmaker Takeda is strengthening its roots in the United States and enriching its global research heft, by unveiling a 165,000-square-foot facility in San Diego, California, in addition to its existing R&D center in Cambridge, Massachusetts and plant in Shonan, Japan.
The new facility, announced on Tuesday, will extend Takeda’s $TAK 14-year presence in San Diego, and is home to more than 250 employees focused on R&D related to gastroenterology and neuroscience.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.